The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 11648/0067.
Glucophage SR 500mg, 750mg and 1000mg prolonged release tablets
Glucophage®SR 500 mg - 750 mg - 1000 mg
Prolonged release tablets
This medicine is intended for adult patients only
1. What Glucophage SR is and what it is used for
2. What you need to know before you take Glucophage SR
3. How to take Glucophage SR
4. Possible side effects
5. How to store Glucophage SR
6. Content of the pack and other information
Glucophage SR prolonged release tablets contain the active ingredient metformin hydrochloride and belong to a group of medicines called biguanides, used in the treatment of Type 2 (non-insulin dependent) diabetes mellitus.
Glucophage SR is used together with diet and exercise to lower the risk of developing Type 2 diabetes in overweight adults, when diet and exercise alone for 3 to 6 months have not been enough to control blood glucose (sugar). You are at high risk of developing Type 2 diabetes if you have additional conditions like high blood pressure, age above 40 years, an abnormal amount of lipids (fat) in the blood or a history of diabetes during pregnancy.
The medicine is particularly effective if you are aged below 45 years, are very overweight, have high blood glucose levels after a meal or developed diabetes during pregnancy.
Glucophage SR is used for the treatment of Type 2 diabetes when diet and exercise changes alone have not been enough to control blood glucose (sugar). Insulin is a hormone that enables body tissues to take glucose from the blood and to use it for energy or for storage for future use. People with Type 2 diabetes do not make enough insulin in their pancreas or their body does not respond properly to the insulin it does make. This causes a build-up of glucose in the blood which can cause a number of serious long-term problems so it is important that you continue to take your medicine, even though you may not have any obvious symptoms.
Glucophage SR makes the body more sensitive to insulin and helps return to normal the way your body uses glucose.
Glucophage SR is associated with either a stable body weight or modest weight loss.
Glucophage SR Prolonged Release Tablets are specially made to release the drug slowly in your body and therefore are different to many other types of tablet containing metformin.
Risk of lactic acidosis.
Glucophage SR may cause a very rare, but very serious side effect called lactic acidosis, particularly if your kidneys are not working properly. The risk of developing lactic acidosis is also increased with uncontrolled diabetes, serious infections, prolonged fasting or alcohol intake, dehydration (see further information below), liver problems and any medical conditions in which a part of the body has a reduced supply of oxygen (such as acute severe heart disease).
If any of the above apply to you, talk to your doctor for further instructions.
Stop taking Glucophage SR for a short time if you have a condition that may be associated with dehydration (significant loss of body fluids) such as severe vomiting, diarrhoea, fever, exposure to heat or if you drink less fluid than normal. Talk to your doctor for further instructions.
Stop taking Glucophage SR and contact a doctor or the nearest hospital immediately if you experience some of the symptoms of lactic acidosis, as this condition may lead to coma.
Symptoms of lactic acidosis include:
Lactic acidosis is a medical emergency and must be treated in a hospital.
If you need to have major surgery you must stop taking Glucophage SR during and for some time after the procedure. Your doctor will decide when you must stop and when to restart your treatment with Glucophage SR.
During treatment with Glucophage SR, your doctor will check your kidney function at least once a year or more frequently if you are elderly and/or if you have worsening kidney function.
If you are older than 75 years, treatment with Glucophage SR should not be started to lower the risk of developing type 2 diabetes.
You may see some remains of the tablets in your stools. Do not worry- this is normal for this type of tablet.
You should continue to follow any dietary advice that your doctor has given you and you should make sure that you eat carbohydrates regularly throughout the day.
Do not stop taking this medicine without speaking to your doctor.
If you need to have an injection of a contrast medium that contains iodine into your bloodstream, for example in the context of an X-ray or scan, you must stop taking Glucophage SR before or at the time of injection. Your doctor will decide when you must stop and when to restart your treatment with Glucophage SR.
Tell your doctor if you are taking, have recently taken or might take any other medicines. You may need more frequent blood glucose and kidney function tests, or your doctor may need to adjust the dosage of Glucophage SR. It is especially important to mention the following:
Avoid excessive alcohol intake while taking Glucophage SR since this may increase the risk of lactic acidosis (see section ‘Warnings and precautions’).
If you are pregnant, think you may be pregnant or are planning to have a baby, speak to your doctor in case any changes will be needed to your treatment or monitoring of your blood glucose levels.
This medicine is not recommended if you are breast-feeding or if you are planning to breast-feed your baby.
Glucophage SR taken on its own does not cause ‘hypos’ (symptoms of low blood sugar or hypoglycaemia, such as faintness, confusion and increased sweating) and therefore should not affect your ability to drive or use machinery.
You should be aware, however, that Glucophage SR taken with other antidiabetic medicines can cause hypos, so in this case you should take extra care when driving or operating machinery.
This medicine contains less than 1mmol sodium (23mg) per dosage unit, that is to say it is essentially ‘sodium free’.
Your doctor may prescribe Glucophage SR for you to take on its own, or in combination with other oral antidiabetic medicines or insulin.
Always take this medicine exactly as your doctor has told you.
You should check with your doctor or pharmacist if you are not sure.
Swallow the tablets whole with a glass of water, do not chew.
Usually you will start treatment with 500 milligrams Glucophage SR daily. After you have been taking Glucophage SR for about 2 weeks, your doctor may measure your blood sugar and adjust the dose. The maximum daily dose is 2000milligrams of Glucophage SR.
If you have reduced kidney function, your doctor may prescribe a lower dose.
Normally, you should take the tablets once a day, with your evening meal.
In some cases, your doctor may recommend that you take the tablets twice a day. Always take the tablets with food.
If you take extra tablets by mistake you need not worry, but if you have unusual symptoms, contact your doctor. If the overdose is large, lactic acidosis is more likely. Symptoms of lactic acidosis are non-specific, such as vomiting, bellyache with muscle cramps, a general feeling of not being well with severe tiredness, and difficulty in breathing. Further symptoms are reduced body temperature and heart beat. If you experience some of these symptoms, you should immediately seek medical attention, as lactic acidosis may lead to coma. Stop taking Glucophage SR immediately and contact a doctor or the nearest hospital straightaway.
Take it as soon as you remember with some food. Do not take a double dose to make up for a forgotten dose.
Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may occur:
Glucophage SR may cause a very rare (may affect up to 1 user in 10,000) but very serious side effect called lactic acidosis (see section ‘Warnings and precautions’). If this happens, you must stop taking the Glucophage SR and contact a doctor or the nearest hospital immediately, as lactic acidosis may lead to coma.
Glucophage SR may cause abnormal liver function tests and hepatitis (inflammation of the liver) which may result in jaundice (may affect up to 1 user in 10,000). If you develop yellowing of the eyes and/or skin contact your doctor immediately.
Other possible side effects are listed by frequency as follows:
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Very rare side effects (may affect up to 1 in 10,000 people):
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date that is printed on the pack after “EXP:”. The expiry date refers to the last day of that month.
This medicinal product does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
Each prolonged release tablet contains 500, 750 or 1000 milligrams of the active ingredient metformin hydrochloride. The other ingredients are magnesium stearate, carmellose sodium and hypromellose.
The 500 milligram tablets are white to off -white and round with ‘500’ on one side.
The 750 milligram tablets are white to off -white and capsule-shaped with ‘750’ on one side and ‘MERCK’ on the other side.
The 1000 milligrams tablets are white to off-white and capsule-shaped with ‘1000’ on one side and ‘MERCK’ on the other side.
Glucophage SR is supplied in packs of 28 and 56 prolonged release tablets.
Glucophage SR 500 mg, 750 mg and 1000 mg Prolonged Release Tablets are manufactured for
This leaflet was last revised in May 2022
If you want more information about diabetes contact: